FDA, NIAAA, AASLD Workshop - Clinical Trial Design and Endpoints for Alcoholic Hepatitis and other Alcohol-Associated Liver Diseases 

Purpose: The purpose of this workshop is to address challenges related to clinical trial designs and drug development in Alcoholic Associated Liver Disease (AALD) and Alcoholic Hepatitis (AH) including populations to study, endpoints, and diagnostic criteria. For details visit https://niaaa.nih.gov/alcoholic-hepatitis-workshop-fda-niaaa-aasld

Registration information: 


Alcoholic Hepatitis Workshop FDA, NIAAA, AASLD Clinical Trial Endpoints for AH